171 related articles for article (PubMed ID: 16223487)
1. Differential selectivity of protein modification by the cyclopentenone prostaglandins PGA1 and 15-deoxy-Delta12,14-PGJ2: role of glutathione.
Gayarre J; Stamatakis K; Renedo M; Pérez-Sala D
FEBS Lett; 2005 Oct; 579(25):5803-8. PubMed ID: 16223487
[TBL] [Abstract][Full Text] [Related]
2. Modification of proteins by cyclopentenone prostaglandins is differentially modulated by GSH in vitro.
Gayarre J; Avellano MI; Sánchez-Gómez FJ; Carrasco MJ; Cañada FJ; Pérez-Sala D
Ann N Y Acad Sci; 2007 Jan; 1096():78-85. PubMed ID: 17405918
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel protein targets for modification by 15-deoxy-Delta12,14-prostaglandin J2 in mesangial cells reveals multiple interactions with the cytoskeleton.
Stamatakis K; Sánchez-Gómez FJ; Pérez-Sala D
J Am Soc Nephrol; 2006 Jan; 17(1):89-98. PubMed ID: 16291835
[TBL] [Abstract][Full Text] [Related]
4. Direct evidence for the covalent modification of glutathione-S-transferase P1-1 by electrophilic prostaglandins: implications for enzyme inactivation and cell survival.
Sánchez-Gómez FJ; Gayarre J; Avellano MI; Pérez-Sala D
Arch Biochem Biophys; 2007 Jan; 457(2):150-9. PubMed ID: 17169324
[TBL] [Abstract][Full Text] [Related]
5. Protein thiol modification by 15-deoxy-Delta12,14-prostaglandin J2 addition in mesangial cells: role in the inhibition of pro-inflammatory genes.
Sánchez-Gómez FJ; Cernuda-Morollón E; Stamatakis K; Pérez-Sala D
Mol Pharmacol; 2004 Nov; 66(5):1349-58. PubMed ID: 15317873
[TBL] [Abstract][Full Text] [Related]
6. Modification and activation of Ras proteins by electrophilic prostanoids with different structure are site-selective.
Renedo M; Gayarre J; García-Domínguez CA; Pérez-Rodríguez A; Prieto A; Cañada FJ; Rojas JM; Pérez-Sala D
Biochemistry; 2007 Jun; 46(22):6607-16. PubMed ID: 17489560
[TBL] [Abstract][Full Text] [Related]
7. Study of protein targets for covalent modification by the antitumoral and anti-inflammatory prostaglandin PGA1: focus on vimentin.
Gharbi S; Garzón B; Gayarre J; Timms J; Pérez-Sala D
J Mass Spectrom; 2007 Nov; 42(11):1474-84. PubMed ID: 17960581
[TBL] [Abstract][Full Text] [Related]
8. Cyclopentenone prostaglandins PGA2 and 15-deoxy-delta12,14 PGJ2 suppress activation of murine microglia and astrocytes: implications for multiple sclerosis.
Storer PD; Xu J; Chavis JA; Drew PD
J Neurosci Res; 2005 Apr; 80(1):66-74. PubMed ID: 15723383
[TBL] [Abstract][Full Text] [Related]
9. Effects of 15-deoxy-delta 12, 14-prostaglandin J2 on the expression of p53 in MCF-7 cells.
Kim DH; Kim EH; Na HK; Surh YJ
Ann N Y Acad Sci; 2009 Aug; 1171():202-9. PubMed ID: 19723057
[TBL] [Abstract][Full Text] [Related]
10. The cyclopentenone 15-deoxy-delta 12,14-prostaglandin J2 binds to and activates H-Ras.
Oliva JL; Pérez-Sala D; Castrillo A; Martínez N; Cañada FJ; Boscá L; Rojas JM
Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4772-7. PubMed ID: 12684535
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of delta 7-prostaglandin A1 and delta 12-prostaglandin J2 in vitro and in vivo.
Kato T; Fukushima M; Kurozumi S; Noyori R
Cancer Res; 1986 Jul; 46(7):3538-42. PubMed ID: 3708585
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of lipopolysaccharide-induced interleukin-10 by prostaglandin A1 in mouse peritoneal macrophages.
Kim HY; Kim JR; Kim HS
J Microbiol Biotechnol; 2008 Jun; 18(6):1170-8. PubMed ID: 18600064
[TBL] [Abstract][Full Text] [Related]
13. Induction of reversible cysteine-targeted protein oxidation by an endogenous electrophile 15-deoxy-delta12,14-prostaglandin J2.
Ishii T; Uchida K
Chem Res Toxicol; 2004 Oct; 17(10):1313-22. PubMed ID: 15487891
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of serum constituents on apoptosis induced by the cyclopentenone prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in WISH epithelial cells.
Berry EB; Sato TA; Mitchell MD; Stewart Gilmour R; Helliwell RJ
Prostaglandins Leukot Essent Fatty Acids; 2004 Sep; 71(3):191-7. PubMed ID: 15253890
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Nrf2-dependent gene expression by 15-deoxy-Delta12,14-prostaglandin J2.
Kansanen E; Kivelä AM; Levonen AL
Free Radic Biol Med; 2009 Nov; 47(9):1310-7. PubMed ID: 19573595
[TBL] [Abstract][Full Text] [Related]
16. Identification of aldo-keto reductase AKR1B10 as a selective target for modification and inhibition by prostaglandin A(1): implications for antitumoral activity.
Díez-Dacal B; Gayarre J; Gharbi S; Timms JF; Coderch C; Gago F; Pérez-Sala D
Cancer Res; 2011 Jun; 71(12):4161-71. PubMed ID: 21507934
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory activity of 15-deoxy-delta12,14-PGJ2 and 2-cyclopenten-1-one: role of the heat shock response.
Ianaro A; Ialenti A; Maffia P; Di Meglio P; Di Rosa M; Santoro MG
Mol Pharmacol; 2003 Jul; 64(1):85-93. PubMed ID: 12815164
[TBL] [Abstract][Full Text] [Related]
18. The 15-deoxy-Delta12,14-prostaglandin J2 inhibits LPS-stimulated AKT and NF-kappaB activation and suppresses interleukin-6 in osteoblast-like cells MC3T3E-1.
Jung WK; Park IS; Park SJ; Yea SS; Choi YH; Oh S; Park SG; Choi IW
Life Sci; 2009 Jul; 85(1-2):46-53. PubMed ID: 19409914
[TBL] [Abstract][Full Text] [Related]
19. A biotinylated analog of the anti-proliferative prostaglandin A1 allows assessment of PPAR-independent effects and identification of novel cellular targets for covalent modification.
Garzón B; Gayarre J; Gharbi S; Díez-Dacal B; Sánchez-Gómez FJ; Timms JF; Pérez-Sala D
Chem Biol Interact; 2010 Jan; 183(1):212-21. PubMed ID: 19800325
[TBL] [Abstract][Full Text] [Related]
20. Induction of apoptosis in estrogen receptor-negative breast cancer cells by natural and synthetic cyclopentenones: role of the IkappaB kinase/nuclear factor-kappaB pathway.
Ciucci A; Gianferretti P; Piva R; Guyot T; Snape TJ; Roberts SM; Santoro MG
Mol Pharmacol; 2006 Nov; 70(5):1812-21. PubMed ID: 16908599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]